2025 annual financial data
BridgeBio Pharma 2025 Net margin
BridgeBio Pharma 2025 net margin with verified reported values.
Direct answer
Net margin was -145.26%.
Operating income was -569,087,000 USD and net income was -729,306,000 USD.
Operating cash flow was -445,910,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 502,078,000 USD
- Operating income
- -569,087,000 USD
- Net income
- -729,306,000 USD
- Operating cash flow
- -445,910,000 USD